Trop‐2 inhibits prostate cancer cell adhesion to fibronectin through the β1 integrin‐RACK1 axis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Trop‐2 is a transmembrane glycoprotein upregulated in several human carcinomas, including prostate cancer (PrCa). Trop‐2 has been suggested to regulate cell–cell adhesion, given its high homology with the other member of the Trop family, Trop‐1/EpCAM, and its ability to bind the tight junction proteins claudin‐1 and claudin‐7. However, a role for Trop‐2 in cell adhesion to the extracellular matrix has never been postulated. Here, we show for the first time that Trop‐2 expression in PrCa cells correlates with their aggressiveness. Using either shRNA‐mediated silencing of Trop‐2 in cells that endogenously express it, or ectopic expression of Trop‐2 in cells that do not express it, we show that Trop‐2 inhibits PrCa cell adhesion to fibronectin (FN). In contrast, expression of another transmembrane receptor, α v β 5 integrin, does not affect cell adhesion to this ligand. We find that Trop‐2 does not modulate either protein or activation levels of the prominent FN receptors, β 1 integrins, but acts through increasing β 1 association with the adaptor molecule RACK1 and redistribution of RACK1 to the cell membrane. As a result of Trop‐2 expression, we also observe activation of Src and FAK, known to occur upon β 1‐RACK1 interaction. These enhanced Src and FAK activities are not mediated by changes in either the activity of IGF‐IR, which is known to bind RACK1, or IGF‐IR's ability to associate with β 1 integrins. In summary, our data demonstrate that the transmembrane receptor Trop‐2 is a regulator of PrCa cell adhesion to FN through activation of the β 1 integrin‐RACK1‐FAK‐Src signaling axis. J. Cell. Physiol. 227: 3670–3677, 2012. © 2012 Wiley Periodicals, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Binding of soluble form of fibroblast surface protein, fibronectin, to collagen
Engvall, E., & Ruoslahti, E. (1977) · International Journal of Cancer · doi:10.1002/ijc.2910200102 · Cited by 1,947
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · cited 1×
“While FAK and Src have intrinsic kinase activities (Lu et al., 1997; Marx et al., 2001; Yeatman, 2004; Mitra et al., 2005), RACK1 is an adaptor molecule known to bind several key signaling proteins, such as activated PKCs (Ron et al., 1994), FAK (Kiely et al., 2009; Serrels et al., 2010) and Src…”
Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu, J. D., Haugk, K., Woodke, L., Nelson, P., Coleman, I., & Plymate, S. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20929 · Cited by 188 · cited 1×
“IGF-I and IGF-IR, known to play a positive role in PrCa (Wu et al., 2006; Zoubeidi et al., 2010), stimulate many signaling pathways upon binding to each other.”
Cited by
Trop2 and its overexpression in cancers: regulation and clinical/ therapeutic implications
Shvartsur, A., & Bonavida, B. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.40 · Cited by 410
The emergence of trophoblast cell-surface antigen 2 (TROP-2) as a novel cancer target
Goldenberg, D. M., Stein, R., & Sharkey, R. M. (2018) · Oncotarget · doi:10.18632/oncotarget.25615 · Cited by 327
Trop-2 is up-regulated in invasive prostate cancer and displaces FAK from focal contacts
Trerotola, M., Ganguly, K. K., Fazli, L., Fedele, C., Lu, H., Dutta, A., Liu, Q., De Angelis, T., Riddell, L. W., Riobo, N. A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3960 · Cited by 70
Self-citationProteomics analysis of E-cadherin knockdown in epithelial breast cancer cells
Vergara, D., Simeone, P., Latorre, D., Cascione, F., Leporatti, S., Trerotola, M., Giudetti, A. M., Capobianco, L., Lunetti, P., Rizzello, A., et al. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2014.10.034 · Cited by 41
Self-citationZHAO, P., YU, H.-Z., & CAI, J.-H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3900 · Cited by 24
Metadata
- Authors
- Trerotola, M., Li, J., Alberti, S., & Languino, L. R.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2012-07-19
- Volume
- 227
- Issue
- 11
- Pages
- 3670-3677
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W1983653351
- Cited by
- 78
- References
- 3
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.